ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EDEN Eden Research Plc

4.25
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.25 4.00 4.50 4.25 4.25 4.25 255,065 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.12 22.67M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.25p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £22.67 million. Eden Research has a price to earnings ratio (PE ratio) of -10.12.

Eden Research Share Discussion Threads

Showing 17351 to 17369 of 17900 messages
Chat Pages: Latest  704  703  702  701  700  699  698  697  696  695  694  693  Older
DateSubjectAuthorDiscuss
24/2/2024
16:01
Information Post

Cavendish price target 20p
Eden share price below 6p
Upside 300%+++

As KittyBiscuits say's, just an information post :)

investingisatrickygame
24/2/2024
13:34
Yap yap yap unfounded speculation (ie, lies) dressed up as tips, or irrelevant stuff like the Corteva appointment presented as if it has ANY BEARING WHATSOEVER on this scamstock's prospects.

You c-nts and specially the shareholding one are headed for jail.

ravenna23 warned you too.

Painful times ahead for you cheats...............

neutralpov
24/2/2024
06:12
Inside the big Network tent.

Lavie Bio
4,215 followers
3yr •

We are happy and excited to announce that Frederic C. Beudot, Global Portfolio Leader for Biologicals at Corteva Agriscience™, is joining the Lavie Bio Board of directors.
With extensive experience in sales, marketing, commercial and strategy of crop protection product, Frederic will allow us to further strengthen our market and commercial focus as we progress toward product launch and pipeline maturation.
We are looking forward to continue the exciting journey with our board of directors – Ofer Haviv, Kristian Bjorneboe, Trevor Thiessen and Frederic C. Beudot.

..............

Frederic Beudot
General Manager - Biologicals Business at Corteva Agriscience

supersonico
23/2/2024
23:01
Super,

let's hope that one of them or ANO makes a shareholder beneficial interest in Eden!!!!!!!!!!!!!

investingisatrickygame
23/2/2024
21:10
From one who follows the story;

Smith @3.50m
"In fact we have only collaborating with Corteva for about four years...We were introduced to a number of folks within the Corteva Europe organisation ..we identified a whole portfolio of products we could work on together"..

Eden Research delivering sustainable alternative to existing seed treatments

supersonico
23/2/2024
20:29
Corteva Agriscience to Invest in Evogene's Agriculture Biologicals Subsidiary, Lavie Bio

Investment Includes Equity and Corteva's Shares in Taxon Biosciences for Shares in Lavie Bio

NEWS PROVIDED BY

Corteva, Inc.
Aug 07, 2019


Corteva, Inc. (NYSE: CTVA), a leading pure-play agriculture company, and Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that Corteva will make an investment in Evogene's agriculture biologicals subsidiary, Lavie Bio (Lavie). The transaction includes the exchange of all shares of Corteva's wholly owned subsidiary Taxon Biosciences along with an equity investment by Corteva in Lavie. As consideration for the Taxon Biosciences shares and equity investment, Corteva will be issued approximately 30 percent of Lavie's equity while Evogene will hold approximately 70 percent of Lavie's equity.

Susanne Wasson, Crop Protection Business Platform President for Corteva Agriscience said, "This transaction demonstrates Corteva's ongoing commitment to bringing to market new and differentiated technologies for our customers." Wasson continued, "We are pleased to collaborate with Lavie Bio – a leader in the field of agriculture biologicals – as we continue to focus on accelerating commercialization of customer-centered innovation in this high-growth sector."

Ofer Haviv, President & CEO of Evogene and Chairman of the Board of Lavie Bio stated, "We are extremely pleased with the combined Taxon acquisition and equity investment by Corteva, a world leader in the agricultural market, following close to two years of a co-development collaboration. By providing both additional complementary technologies along with potential go-to-market pathways, we believe this transaction will significantly enhance Lavie's capabilities for the development and commercialization of next generation agriculture biological products."

Ido Dor, Lavie Bio's CEO, stated, "We are very pleased that Corteva, a world leading agricultural company, continues to partner with Lavie. I am confident that with Corteva's leadership in agriculture innovation, and the complementary capabilities which we will add through the acquisition of Taxon Biosciences, Lavie is well positioned to achieve its mission of improving food quality, agricultural sustainability and productivity through the introduction of next generation microbiome-based agriculture biological products."

Agriculture biologicals include externally-applied products derived from natural, biological sources such as microbials, macrobials, biochemicals and minerals to optimize overall plant health. Agriculture biological products include bio-stimulants, for maximizing plant yield and durability, as well as bio-pesticides for insect management. The agriculture biologicals sector is a growing segment of the agriculture inputs market.

Full release -

supersonico
23/2/2024
19:51
Syngenta and Lavie Bio announce partnership to discover and develop novel bio-insecticide.

Feb 20 2024
Agreement reinforces both companies’ commitment to developing and bringing innovative biological solutions to farmers
Basel / Switzerland, and Rehovot, Israel, 20 Feb 2024 – Syngenta Crop Protection, a leader in agricultural innovation, and Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biologicals company, today announced an agreement for the discovery and development of new biological insecticidal solutions.

The collaboration will leverage Lavie Bio's unique technology platform to rapidly identify and optimize bio-insecticide candidates, as well as Syngenta’s extensive global research, development and commercialization capabilities.

Insects pose a major challenge to the health of crops worldwide, directly injuring plants as they feed on the plant’s stems, fruit and roots, as well as indirectly by transmitting bacterial, viral and fungal infections to crops – costing the global economy an estimated $70 billion a year, according to the UN’s Food and Agriculture Organization. Experts predict such losses will worsen with global warming widening the spread of invasive insect risk and rising resistance to available insecticides.

“Syngenta is a leader in advancing sustainable agriculture and we are thrilled to collaborate with Lavie Bio in biocontrol innovation and bring novel modes of action in the growers’ toolbox to combat insect resistance,” said Camilla Corsi, Global Head of Research at Syngenta Crop Protection. “This collaboration underscores Syngenta's commitment to collaborating with cutting-edge agricultural technology companies, merging digital and experimental approaches to accelerate and diversify innovation.”

"We're excited to collaborate with Syngenta, a world leader in agricultural innovation," said Amit Noam, CEO of Lavie Bio. "Both companies share a mutual commitment to sustainable farming and together, we aim to develop an impactful bio-insecticide product. Lavie Bio's unique computational capabilities and Syngenta's vast experience in developing and commercializing innovative products make this partnership significant. We enthusiastically look forward to joining forces to achieve the mutual task of insect management in agriculture."

supersonico
23/2/2024
15:56
That’ll be me Tom. Don’t you worry your little grey cells about it.
kittybiscuits
23/2/2024
15:11
He who laughs last....
neutralpov
22/2/2024
14:59
Oooh, touched a nerve have we. Told you before, feel free to pass my details onto the fca, pra, police, feds, even the rspca if it makes you feel better.

You won’t of course, as you are just a troll.

kittybiscuits
21/2/2024
19:53
He is probably the one behind this idiot, if not the same person.
kittybiscuits
21/2/2024
14:46
I think S Smith you should harmonise fundamentals with the technicals . As we said at my old place "news moves markets ".
alchemy
21/2/2024
12:49
There is someone, but the name escapes me ... poacher to gamekeeper vibe. Neuts has referenced him before...
timbo_slice
21/2/2024
11:54
Timbo, there is no expose. There won't be one. There are no rumours. There is no FCA, investigation and the police are not raiding properties looking for evidence. It's all in his head.
kittybiscuits
21/2/2024
11:18
I look forward to the expose you are preparing where these questions are answered.
timbo_slice
21/2/2024
10:37
Be that as it may this seems to have become an afternoon stock . Does that mean activity in the new world has had some effects?
alchemy
21/2/2024
08:09
Yes a very visible Golden Cross as foretold by observant poster yesterday
alchemy
21/2/2024
07:46
Yet another series of posts where you claim to know everyone who posts here is a liar, cheat and scammer - yet all you are is a bitter, sad, loner who lost a fortune and wants revenge!
kittybiscuits
21/2/2024
02:28
Cos both of you are going to the same place, though I suspect only one of you will get the full 20 years.

I already know about your poor record at school and your feelings of inferiority. You got that right, at least.

Now FOAD.

neutralpov
Chat Pages: Latest  704  703  702  701  700  699  698  697  696  695  694  693  Older

Your Recent History

Delayed Upgrade Clock